Literature DB >> 17392855

Giant cell arteritis in a neuro-ophthalmology clinic in Saskatoon, 1998-2003.

Cory L Ramstead1, Anil D Patel.   

Abstract

BACKGROUND: We present a retrospective review of all biopsy-positive cases of giant cell arteritis (GCA) presenting to a neuro-ophthalmology practice in Saskatoon, Saskatchewan.
METHODS: Records of 141 consecutive patients who underwent temporal artery biopsy at the Saskatoon Eye Centre from July 1998 through June 2003 were reviewed. Patients that were biopsy-positive for GCA were studied and an estimated regional incidence was calculated. Study variables included age at diagnosis, sex, ethnicity, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP) level.
RESULTS: Of 141 patients, 37 (26%) had a positive biopsy result for GCA; 11 underwent a second biopsy for a total of 152 biopsies. The average age of the biopsy-positive patients was 76.5 (SD 8.2) years, and the female-to-male ratio was 2.4:l. There were 35 patients (95%) of European descent and 2 patients (5%) of Aboriginal descent. Twenty-three patients had both ESR and CRP testing done before starting steroids. The ESR was elevated in 19 (83%) and the CRP in 22 (96%). The estimated incidence of GCA for Saskatoon and area was 9.4 per 100,000 for people over the age of 50 years.
INTERPRETATION: GCA occurs primarily in people of European descent; however, it can affect North American people of Aboriginal descent. Sensitivity for the detection of GCA is higher in CRP than in ESR. The estimated incidence of GCA in Saskatoon and surrounding referral area is moderate compared with other northern areas.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17392855     DOI: 10.3129/can j ophthalmol.i07-005

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  7 in total

Review 1.  The geo-epidemiology of temporal (giant cell) arteritis.

Authors:  Jennifer L Lee; Stanley M Naguwa; Gurtej S Cheema; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2008-10       Impact factor: 8.667

Review 2.  Giant cell arteritis and polymyalgia rheumatica: current challenges and opportunities.

Authors:  Christian Dejaco; Elisabeth Brouwer; Justin C Mason; Frank Buttgereit; Eric L Matteson; Bhaskar Dasgupta
Journal:  Nat Rev Rheumatol       Date:  2017-09-14       Impact factor: 20.543

3.  Giant cell arteritis in patients of Indian Subcontinental descent in the UK.

Authors:  N Tan; J Acheson; N Ali
Journal:  Eye (Lond)       Date:  2018-10-12       Impact factor: 3.775

4.  The Adequate Number of Histopathology Cross-sections of Temporal Artery Biopsy in Establishing the Diagnosis of Giant Cell Arteritis.

Authors:  Roshanak Ali-Akbar Navahi; Samira Chaibakhsh; Sayyed Amirpooya Alemzadeh; Kaveh Abri Aghdam
Journal:  J Ophthalmic Vis Res       Date:  2021-01-20

5.  Trend and Geographic Disparities in the Mortality Rates of Primary Systemic Vasculitis in the United States from 1999 to 2019: A Population-Based Study.

Authors:  Alicia Rodriguez-Pla; Jose Rossello-Urgell
Journal:  J Clin Med       Date:  2021-04-18       Impact factor: 4.964

6.  Association of HLA-DRB1 amino acid residues with giant cell arteritis: genetic association study, meta-analysis and geo-epidemiological investigation.

Authors:  Sarah Louise Mackie; John C Taylor; Lubna Haroon-Rashid; Stephen Martin; Bhaskar Dasgupta; Andrew Gough; Michael Green; Lesley Hordon; Stephen Jarrett; Colin T Pease; Jennifer H Barrett; Richard Watts; Ann W Morgan
Journal:  Arthritis Res Ther       Date:  2015-07-30       Impact factor: 5.156

7.  Does herpes zoster predispose to giant cell arteritis: a geo-epidemiologic study.

Authors:  Edsel B Ing; Royce Ing; Xinyang Liu; Angela Zhang; Nurhan Torun; Michael Sey; Christian Pagnoux
Journal:  Clin Ophthalmol       Date:  2018-01-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.